国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

CCR3

CCR3(C-C趨化因子受體3)是一種主要分布于嗜酸性粒細(xì)胞、嗜堿性粒細(xì)胞及Th2細(xì)胞的G蛋白偶聯(lián)受體,也被稱為CD193。該蛋白通過與Eotaxin等趨化因子結(jié)合,調(diào)控免疫細(xì)胞向炎癥部位遷移,尤其在過敏性疾病中扮演核心角色。研究發(fā)現(xiàn),其在哮喘患者的呼吸道、過敏性鼻炎鼻黏膜及特應(yīng)性皮炎皮損部位異常活躍,與嗜酸性粒細(xì)胞浸潤直接相關(guān)。近年還發(fā)現(xiàn)某些實(shí)體瘤微環(huán)境中CCR3高表達(dá),可能參與腫瘤免疫逃逸,例如結(jié)腸癌中CCR3信號可能促進(jìn)血管生成。

針對CCR3的藥物研發(fā)曾聚焦于小分子拮抗劑,如GSK766994等早期候選藥物在臨床試驗(yàn)中因療效不足或脫靶效應(yīng)未能突破。目前策略轉(zhuǎn)向聯(lián)合療法,例如將CCR3抑制劑與抗IgE抗體奧馬珠單抗聯(lián)用,或開發(fā)雙功能抗體同時(shí)阻斷CCR3與IL-5通路。2022年跨國藥企公布的臨床前數(shù)據(jù)顯示,新型變構(gòu)抑制劑可選擇性抑制嗜酸性粒細(xì)胞遷移而不影響其他免疫細(xì)胞,為減少副作用提供新方向。但該靶點(diǎn)成藥性挑戰(zhàn)仍存,需進(jìn)一步驗(yàn)證其在復(fù)雜炎癥網(wǎng)絡(luò)中的調(diào)控機(jī)制。

熱銷產(chǎn)品

CCR3 Antibody (CSB-PA004842LA01HU)

驗(yàn)證數(shù)據(jù)

CSB-PA004842LA01HU

Western Blot
Positive WB detected in: Mouse liver tissue
All lanes: CCR3 antibody at 3μg/ml
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
predicted band size: 42, 44 kDa
observed band size: 42 kDa

CSB-PA004842LA01HU

Immunohistochemistry of paraffin-embedded human liver tissue using CSB-PA004842LA01HU at dilution of 1:100

CSB-PA004842LA01HU

Immunofluorescent analysis of A549 cells using CSB-PA004842LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

CCR3 Antibodies

CCR3 for Homo sapiens (Human)

CCR3 Proteins

CCR3 Proteins for Homo sapiens (Human)

CCR3 Proteins for Mus musculus (Mouse)

CCR3 Proteins for Macaca mulatta (Rhesus macaque)

CCR3 Proteins for Rattus norvegicus (Rat)

CCR3 Proteins for Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)

CCR3 Proteins for Canis familiaris (Dog) (Canis lupus familiaris)

CCR3 Proteins for Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)

CCR3 Proteins for Arabidopsis thaliana (Mouse-ear cress)